{"id":54987,"date":"2023-03-20T14:03:23","date_gmt":"2023-03-20T13:03:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/"},"modified":"2023-03-20T14:03:23","modified_gmt":"2023-03-20T13:03:23","slug":"veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/","title":{"rendered":"Veranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign"},"content":{"rendered":"
\n

\nVeranex is the first medtech innovation solutions firm to sponsor Stanford Biodesign\n<\/p>\n

RALEIGH, N.C.–(BUSINESS WIRE)–#biodesign<\/a>—Veranex<\/a>, the only truly comprehensive, global, tech-enabled service provider dedicated to the medtech industry, today announced that it has joined industry leaders as corporate sponsors for the Stanford Byers Center for Biodesign<\/a>. Stanford Biodesign trains and supports students, fellows, faculty, and global executives in healthcare technology innovation. Veranex is the first medtech innovation solutions firm to sponsor the program.\n<\/p>\n

<\/a><\/p>\n

\n\u201cWe\u2019re honored to join industry leaders in supporting Stanford Biodesign because we share their commitment to innovation education and achieving the extraordinary,\u201d said Pat Donnelly, Chairman and CEO of Veranex. \u201cWe believe the future of better healthcare relies on advancing human-centered biodesign, and we\u2019re grateful to play a role in forging this future with a new generation of engineers and entrepreneurs focused on positively impacting the lives of patients.\u201d\n<\/p>\n

\n\u201cWe are excited to have Veranex\u2019s support to help us further our mission of advancing health outcomes and equity through innovation education, translation, and policy. A close, two-way interface with medtech industry leadership has been a hallmark of Stanford Biodesign from its inception,\u201d said Josh Makower, the Yock Family Professor of Medicine and Bioengineering at the Stanford University Schools of Medicine and Engineering and Director and Co-founder of the Stanford Byers Center for Biodesign.\n<\/p>\n

\nStanford Biodesign was founded over 20 years ago to create an ecosystem of training and support for Stanford University students, fellows, and faculty with the talent and ambition to become health technology innovators. The non-profit program\u2019s need-driven innovation process now has become the foundation of health technology training programs worldwide, and has been adopted by a majority of the leading multi-national medtech companies into their core business development and upstream R&D programs.\n<\/p>\n

\n\u201cThe Stanford Byers Center for Biodesign represents the gold standard for human-centered design\u2014principles that are deeply rooted in the legacy of Veranex design and engineering,\u201d said Jim Maciariello, Senior Vice President and General Manager of Product Design and Engineering at Veranex. \u201cThrough this sponsorship, we hope to support the continued transformation of how medtech is designed, collaborating with our clients to create better solutions that exemplify the proven methods and values of Stanford Biodesign.\u201d\n<\/p>\n

\nDr. Makower and Stanford Biodesign board member and Chief Scientific Officer of Edwards Lifesciences, Todd Brinton, will join Lisa Carmel, EVP of Strategic Partnerships for Veranex, at Life Science Intelligence (LSI)\u2019s Emerging MedTech Summit<\/a> thought leadership panel, \u201cPowering Up Innovation in a Digital, Connected World.\u201d The panel takes place on March 23, 2023, 8:40-9:20 am PST. More information, including the complete list of panelists, can be found here<\/a>.\n<\/p>\n

\nAbout Veranex Solutions<\/b>\n<\/p>\n

\nVeranex is the only truly comprehensive, global, tech-enabled service provider dedicated to the MedTech industry. Offering expert guidance from concept to commercialization and across the development continuum, Veranex enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment. At every stage, Veranex customers realize efficiencies in cost and time, while its comprehensive solutions unify and streamline the entire development process. Veranex is backed by Summit Partners<\/a>, Accelmed<\/a>, and Lauxera<\/a>. For more information, visit Veranex.com<\/a> and follow Veranex on LinkedIn<\/a>.\n<\/p>\n

\nAbout Stanford Byers Center for Biodesign<\/b>\n<\/p>\n

\nCo-founded in 2001 at Stanford University by Paul Yock, MD, and Josh Makower, MD, the Stanford Byers Center for Biodesign is committed to advancing health outcomes and equity through innovation education, translation, and policy. Stanford Biodesign believes that diversity across multiple dimensions inspires creativity and helps foster innovation for all patient populations. To date, more than 7.6 million people have been helped by technologies invented during Stanford Biodesign training, and the biodesign innovation process has been widely adopted by universities and training programs around the world. For more information about Stanford Biodesign, please visit biodesign.stanford.edu<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nContact<\/b>: Brittany Kearns
\n
Phone<\/b>: 571-271-7211
\n
Email<\/b>: brittany@crossroadsb2b.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Veranex is the first medtech innovation solutions firm to sponsor Stanford Biodesign RALEIGH, N.C.–(BUSINESS WIRE)–#biodesign—Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medtech industry, today announced that it has joined industry leaders as corporate sponsors for the Stanford Byers Center for Biodesign. Stanford Biodesign trains and supports students, fellows, faculty, and … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54987","6":"format-standard","7":"category-industry"},"yoast_head":"\nVeranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Veranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Veranex is the first medtech innovation solutions firm to sponsor Stanford Biodesign RALEIGH, N.C.–(BUSINESS WIRE)–#biodesign—Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medtech industry, today announced that it has joined industry leaders as corporate sponsors for the Stanford Byers Center for Biodesign. Stanford Biodesign trains and supports students, fellows, faculty, and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-20T13:03:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230320005161\/en\/1741886\/21\/Veranex_Logo_CMYK.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Veranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign\",\"datePublished\":\"2023-03-20T13:03:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\\\/\"},\"wordCount\":656,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005161\\\/en\\\/1741886\\\/21\\\/Veranex_Logo_CMYK.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\\\/\",\"name\":\"Veranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005161\\\/en\\\/1741886\\\/21\\\/Veranex_Logo_CMYK.jpg\",\"datePublished\":\"2023-03-20T13:03:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005161\\\/en\\\/1741886\\\/21\\\/Veranex_Logo_CMYK.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005161\\\/en\\\/1741886\\\/21\\\/Veranex_Logo_CMYK.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Veranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Veranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/","og_locale":"en_US","og_type":"article","og_title":"Veranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign - Pharma Trend","og_description":"Veranex is the first medtech innovation solutions firm to sponsor Stanford Biodesign RALEIGH, N.C.–(BUSINESS WIRE)–#biodesign—Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medtech industry, today announced that it has joined industry leaders as corporate sponsors for the Stanford Byers Center for Biodesign. Stanford Biodesign trains and supports students, fellows, faculty, and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-20T13:03:23+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230320005161\/en\/1741886\/21\/Veranex_Logo_CMYK.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Veranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign","datePublished":"2023-03-20T13:03:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/"},"wordCount":656,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230320005161\/en\/1741886\/21\/Veranex_Logo_CMYK.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/","url":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/","name":"Veranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230320005161\/en\/1741886\/21\/Veranex_Logo_CMYK.jpg","datePublished":"2023-03-20T13:03:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230320005161\/en\/1741886\/21\/Veranex_Logo_CMYK.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230320005161\/en\/1741886\/21\/Veranex_Logo_CMYK.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/veranex-joins-industry-leaders-as-a-sponsor-for-the-stanford-byers-center-for-biodesign\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Veranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54987"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54987\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}